Scynexis Inc

SCYX chart

Scynexis Inc news

• SCYNEXIS at guggenheim healthcare conference: dual-pipeline push

  Investing.com · Nov 9, 3:16 PM EST

• SCYNEXIS (SCYX) Falls 11.72% to $3.39, Testing Key Support at $3.22 - Symmetrical Triangle

  www.siam.in · Nov 5, 3:34 PM EST

• Scynexis Inc earnings missed by $0.10, revenue fell short of estimates

  Investing.com · Nov 5, 11:40 AM EST

• SCYNEXIS Inc reports results for the quarter ended September 30 - Earnings Summary

  TradingView · Nov 5, 10:33 AM EST

• Scynexis posts Q3 net loss on higher R&D costs

  TradingView · Nov 5, 8:31 AM EST

• No additional securities are registered as SCYNEXIS (SCYX) proposes a replacement $200M offering plan.

  Stock Titan · Nov 5, 8:30 AM EST

• Scynexis: Q3 Earnings Snapshot

  Yahoo Finance · Nov 5, 8:27 AM EST

• SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update

  Yahoo Finance · Nov 5, 8:20 AM EST

• Press Release: SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update

  Moomoo · Nov 5, 8:20 AM EST

• Up to $214 million could fund SCYNEXIS's work on a treatment for serious fungal infections if options are exercised.

  Stock Titan · Nov 5, 8:20 AM EST

• SCYNEXIS 3Q 2026: Revenue $0, EPS ($0.71) — 10-Q Summary

  TradingView · Nov 5, 8:11 AM EST

• License revenue falls 88% as SCYNEXIS (SCYX) posts a wider nine-month loss.

  Stock Titan · Nov 5, 8:02 AM EST

Scynexis Inc key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-05
• 8-K8-K2026-09-28
• 8-K8-K2026-09-22
• 8-K8-K2026-09-10
• 10-Q10-Q2026-08-10
• 8-K8-K2026-06-26
• 8-K8-K2026-05-29
• 8-K8-K2026-05-22
• 10-Q10-Q2026-05-11
• DEF 14ADEF 14A2026-04-30
• DEF 14ADEF 14A2026-04-27
• 8-K8-K2026-04-20

About Scynexis Inc

Ticker

SCYX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Jersey City, NJ

Fiscal year end

December 31

SEC CIK

1178253

Frequently asked questions